NEWS 🚨
Iptacopan receives FDA approval for C3 glomerulopathy
Treatment with iptacopant resulted in clinically meaningful proteinuria reduction, which was seen as early as 14 days and sustained at 12 months
globenewswire.com/news-relea…
ANCA-negative pauci-immune GN is reported to occur in up to 30% of cases; in Europe, it has a prevalence of 1-5% of cases. Our multi-centre series reported the largest cohort of 132 cases and was just published in @KIReportskireports.org/article/S2468-…
Baseline char. are given!
Come join us for #IVW2026 in Australia, and in the vibrant city of Melbourne! February offers perfect summer weather - ideal for beach trips and exploring the city’s famous laneways. Join the Mailing List (vasculitis-melbourne2026.com…) to keep up to date!
The 2025 ISN Leadership Election results were announced during the ISN General Assembly meeting today at #ISNWCN. Welcome to 2025-27 ISN President-elect, Liz Lightstone (UK),
Join @goKDIGO Guideline Education Meetings (GEMS)
#Nephpearls
🗓️ January 13-14, 2025
⏰ Check your Time Zone (Europe and Asia; USA and Europe)
REGISTER 👉 gems-gd.org/home#overview
📌 A new program offering virtual education on the latest KDIGO Guidelines and evidence-based updates
📌 This innovative program will provide a comprehensive understanding of how to apply KDIGO's evidence-based recommendations and practice points most effectively
📌 The first-ever guideline implementation program will focus on glomerular diseases (Lupus Nephritis, ANCA-associated Vasculitis, IgA Nephropathy, & Complement-Mediated Kidney Disease)
Our multi-continental study on differences in phenotypes, treatments and outcomes of AAV started as a survey to see how induction therapy has changed during the pandemic (Jan 2020-Jun 2020). But we did not see any.
Follow-up investigations revealed differences in GFR at baseline
Just published in @Kidney_Int - The impact of PLEX and GC on early kidney function changes in AAV. (kidney-international.org/art…) This analysis provides another important piece of the “PLEX puzzle”.
Many thanks to my co-authors, the PIs and especially to @AKronbichler and David Jayne.
Excellent vasculitis sessions at #ASNKidneyWeek@ASNKidney To immerse yourself in all forms of #vasculitis to learn and work collaboratively across disciplines come to Melbourne - Feb 2026 - for the 22nd Int Vasculitis Workshop. Register your interest at
vasculitis-melbourne2026.com
🌟Join our Glomerular Diseases Fellowship @hopkinsneph for July 2024 - June 2025!🌟
🔬 Dive into rare diseases, research & patient care
📚 Comprehensive training in nephrology
🌎 ACGME residency and nephrology fellowship required
🌐 J1/H1B visas welcome
📄 Application details 👇